Search details
1.
Inspiring New Science to Guide Healthcare in Turner Syndrome: Rationale, design, and methods for the InsighTS Registry.
Am J Med Genet A
; 194(2): 311-319, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37827984
2.
Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations.
Am J Med Genet A
; 179(4): 542-551, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30719864
3.
Gonadotropin-Releasing Hormone (GnRHa) Therapy for Central Precocious Puberty (CPP): Review of Nuances in Assessment of Height, Hormonal Suppression, Psychosocial Issues, and Weight Gain, with Patient Examples.
Pediatr Endocrinol Rev
; 15(4): 298-312, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29806750
4.
Incidence of central precocious puberty declines to pre-pandemic levels post COVID-19 pandemic increase: single-center retrospective review in the United States.
Front Pediatr
; 12: 1352295, 2024.
Article
in English
| MEDLINE | ID: mdl-38545431
5.
Treatment of Central Precocious Puberty with a Focus on Girls.
Endocrinol Metab Clin North Am
; 53(2): 229-238, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38677866
6.
Unstimulated Luteinizing Hormone for Assessment of Suppression During Treatment of Central Precocious Puberty with 6-Month Subcutaneous Leuprolide Acetate: Correlations with Clinical Response.
Horm Res Paediatr
; 2024 Apr 29.
Article
in English
| MEDLINE | ID: mdl-38684152
7.
Timing of onset of menses after GnRH agonist treatment for central precocious puberty.
J Pediatr Endocrinol Metab
; 37(5): 451-461, 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38618862
8.
Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome.
Eur J Endocrinol
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38748847
9.
Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty.
J Pediatr Endocrinol Metab
; 36(3): 299-308, 2023 Mar 28.
Article
in English
| MEDLINE | ID: mdl-36473097
10.
Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study.
J Endocr Soc
; 7(7): bvad071, 2023 Jun 05.
Article
in English
| MEDLINE | ID: mdl-37334213
11.
No pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty.
J Pediatr Endocrinol Metab
; 35(11): 1401-1409, 2022 Nov 25.
Article
in English
| MEDLINE | ID: mdl-36114751
12.
Incidence of central precocious puberty more than doubled during COVID-19 pandemic: Single-center retrospective review in the United States.
Front Pediatr
; 10: 1007730, 2022.
Article
in English
| MEDLINE | ID: mdl-36533230
13.
Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States.
Front Pediatr
; 10: 968485, 2022.
Article
in English
| MEDLINE | ID: mdl-36268040
14.
Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 years.
J Pediatr Endocrinol Metab
; 34(6): 733-739, 2021 Jun 25.
Article
in English
| MEDLINE | ID: mdl-33856747
15.
A survey of care pathway and health-related quality of life impact for children with central precocious puberty.
Curr Med Res Opin
; 36(3): 411-418, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31778082
16.
Treatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: an examination of the commercial and Medicaid populations.
J Med Econ
; 23(4): 407-414, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-31766907
17.
Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
J Clin Endocrinol Metab
; 105(10)2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32738042
18.
Importance of leuprolide acetate variable dosing for precocious puberty: a range of acceptable suppression.
J Pediatr Endocrinol Metab
; 22(7): 629-34, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19774844
19.
Review of Hormone Replacement Therapy in Girls and Adolescents with Hypogonadism.
J Pediatr Adolesc Gynecol
; 32(5): 460-468, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31059821
20.
Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium.
Horm Res Paediatr
; 91(6): 357-372, 2019.
Article
in English
| MEDLINE | ID: mdl-31319416